Consistent with this, mice with compound Dnmt3a and Tet2 mutations (including Dnmt3a−/−Tet2−/− or DnMt3aR882HTet2−/−) developed multiple types of hematologic malignancies including AITL, AML, and T-ALL. This evidence concerns the gene DNMT3A and acute myeloid leukemia.